May 30 (SeeNews) - Bulgarian blue-chip drug maker Sopharma on Friday said its first-quarter consolidated net profit fell 14% on the year to 7.48 million levs ($5.9 million/3.8 million euro) as operating costs rose faster than sales revenue.